Apogee Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
/ 
Frequently asked questions
To buy Apogee Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Apogee Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Apogee Therapeutics Inc. is APGE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Apogee Therapeutics Inc. has its primary listing on NASDAQ. You can trade Apogee Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Apogee Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Apogee Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Apogee Therapeutics Inc. or others.